Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 Oct, 2018 to 02 Nov, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Curcuma longa, essential oil obtained by steam distillation of the leaves
- Molecular formula:
- No applicable for UVCB substance
- IUPAC Name:
- Curcuma longa, essential oil obtained by steam distillation of the leaves
- Test material form:
- liquid
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- The S9 Microsomal fractions (CD Sprague-Dawley) were pre-prepared using standardized in-house procedures (outside the confines of this study). Lot No. PB/βNF S9 31 August 2018 was used in this study.
The S9-mix was prepared before use using sterilized co-factors and maintained on ice for the duration of the test.
S9 5.0 mL
1.65 M KCl/0.4 M MgCl2 1.0 mL
0.1 M Glucose-6-phosphate 2.5 mL
0.1 M NADP 2.0 mL
0.2 M Sodium phosphate buffer (pH 7.4) 25.0 mL
Sterile distilled water 14.5 mL
A 0.5 mL aliquot of S9-mix and 2 mL of molten, trace histidine or tryptophan supplemented, top agar were overlaid onto a sterile Vogel-Bonner Minimal agar plate in order to assess the sterility of the S9-mix. This procedure was repeated, in triplicate, on the day of each experiment. - Test concentrations with justification for top dose:
- Experiment 1 - Plate incorporation method
The test item was tested using the following method. The maximum concentration was 5000 μg/plate (the OECD TG 471 maximum recommended dose level). Eight concentrations of the test item (1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate) were assayed in triplicate against each tester strain, using the direct plate incorporation method.
Experiment 2 – Pre-Incubation Method
The dose range used for Experiment 2 was determined by the results of Experiment 1 and was initially 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate. However, results from the second mutation test showed that the toxicity of the test item yielded results that differed significantly from Experiment 1 and consequently an insufficient number of non-toxic dose levels were attained for TA100, TA98 and TA1537 in the absence of metabolic activation (S9-mix). Therefore, these strains were repeated employing an amended test item dose range as follows: 0.05, 0.15, 0.5, 1.5, 5, 15, 50 and 150 μg/plate.
Eight test item concentrations per bacterial strain were selected in Experiment 2 in order to achieve both four non-toxic dose levels and the toxic limit of the test item following the change in test methodology. - Vehicle / solvent:
- The test item was immiscible in sterile distilled water and dimethyl sulphoxide at 50 mg/mL but was fully miscible in acetone at 100 mg/mL in solubility checks performed in-house. Acetone was therefore selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other:
- Details on test system and experimental conditions:
- Test Item Preparation and Analysis
The test item was accurately weighed and, on the day of each experiment, approximate half-log dilutions prepared in pre-dried acetone by mixing on a vortex mixer. The test item was confirmed as a UVCB substance, therefore no correction for purity was required. Acetone is toxic to the bacterial cells at 0.1 mL (100 μL) after employing the pre-incubation modification; therefore all of the formulations for Experiment 2 were prepared at concentrations two times greater than required on Vogel-Bonner agar plates. To compensate, each formulation was dosed using 0.05 mL (50 μL) aliquots (Maron et al., 1981).
All formulations were used within four hours of preparation and were assumed to be stable for this period.
Test for Mutagenicity: Experiment 1 – Plate Incorporation Method
Without Metabolic Activation
A 0.1 mL aliquot of the appropriate concentration of test item, solvent vehicle or 0.1 mL of the appropriate positive control was added together with 0.1 mL of the bacterial strain culture, 0.5 mL of phosphate buffer and 2 mL of molten, trace amino-acid supplemented media. These were then mixed and overlayed onto a Vogel-Bonner agar plate. Negative (untreated) controls were also performed on the same day as the mutation test. Each concentration of the test item, appropriate positive, vehicle and negative controls, and each bacterial strain, was assayed using triplicate plates.
With Metabolic Activation
The procedure was the same as described previously (see 3.3.2.2) except that following the addition of the test item formulation and bacterial culture, 0.5 mL of S9-mix was added to the molten, trace amino-acid supplemented media instead of phosphate buffer.
Incubation and Scoring
All of the plates were incubated at 37 ± 3 °C for between 48 and 72 hours and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity).
Test for Mutagenicity: Experiment 2 – Pre-Incubation Method
As the result of Experiment 1 was considered negative, Experiment 2 was performed using the pre-incubation method in the presence and absence of metabolic activation (S9-mix).
Without Metabolic Activation
A 0.1 mL aliquot of the appropriate bacterial strain culture, 0.5 mL of phosphate buffer and 0.05 mL of the appropriate concentration of test item formulation, solvent vehicle or 0.1 mL of appropriate positive control were incubated at 37 ± 3 °C for 20 minutes (with shaking) prior to addition of 2 mL of molten, trace amino-acid supplemented media and subsequent plating onto Vogel-Bonner plates. Negative (untreated) controls were also performed on the same day as the mutation test employing the plate incorporation method. All testing for this experiment was performed in triplicate.
With Metabolic Activation
The procedure was the same as described previously (see 3.3.3.2) except that following the addition of the test item formulation and bacterial strain culture, 0.5 mL of S9-mix was added to the tube instead of phosphate buffer, prior to incubation at 37 ± 3 °C for 20 minutes (with shaking) and addition of molten, trace amino-acid supplemented media. All testing for this experiment was performed in triplicate.
All of the plates were incubated at 37 ± 3 °C for between 48 and 72 hours and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity). - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. A fold increase greater than two times the concurrent solvent control for TA100, TA98 and WP2uvrA or a three-fold increase for TA1535 and TA1537 (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
5. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Test Results: Experiment 1 – Without Metabolic Activation (Plate Incorporation)
Test Period | From: 16 October 2018 | To: 19 October 2018 | ||||||||||
S9-Mix (-) | Dose Level Per Plate | Number of revertants (mean) +/- SD | ||||||||||
Base-pair substitution strains | Frameshift strains | |||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | ||||||||
Solvent Control (Acetone) | 137 104 129 | (123) 17.2# | 17 23 22 | (21) 3.2 | 19 28 28 | (25) 5.2 | 36 30 23 | (30) 6.5 | 20 12 27 | (20) 7.5 | ||
1.5 µg | 157 116 132 | (135) 20.7 | 20 15 23 | (19) 4.0 | 24 42 37 | (34) 9.3 | 22 23 20 | (22) 1.5 | 19 12 20 | (17) 4.4 | ||
5 µg | 141 122 134 | (132) 9.6 | 22 21 22 | (22) 0.6 | 17 21 24 | (21) 3.5 | 21 16 17 | (18) 2.6 | 9 7 21 | (12) 7.6 | ||
15 µg | 130 137 118 | (128) 9.6 | 13 13 16 | (14) 1.7 | 23 22 28 | (24) 3.2 | 12 16 14 | (14) 2.0 | 20 8 24 | (17) 8.3 | ||
50 µg | 122 116 117 | (118) 3.2 | 19 23 20 | (21) 2.1 | 17 22 29 | (23) 6.0 | 18 16 19 | (18) 1.5 | 9 18 11 | (13) 4.7 | ||
150 µg | 128 127 119 | (125) 4.9 | 29 13 15 | (19) 8.7 | 34 29 30 | (31) 2.6 | 13 20 27 | (20) 7.0 | 16 11 6 | (11) 5.0 | ||
500 µg | 125 125 119 | (123) 3.5 | 21 26 23 | (23) 2.5 | 25 23 26 | (25) 1.5 | 23 22 16 | (20) 3.8 | 7 4 4 | (5) 1.7 | ||
1500 µg | 115 S 116 S 108 S | (113) 4.4 | 11 S 25 S 25 S | (20) 8.1 | 19 S 26 S 30 S | (25) 5.6 | 17 19 21 | (19) 2.0 | 7 S 9 S 6 S | (7) 1.5 | ||
5000 µg | 36 SF 32 SF 45 SF | (38) 6.7 | 11 SF 9 SF 9 SF | (10) 1.2 | 25 SF 41 SF 29 SF | (32) 8.3 | 24 SF 17 SF 18 SF | (20) 3.8 | 0 VF 0 VF 0 VF | (0) 0.0 | ||
Positive controls S9-Mix (-) | Name Dose Level No. of Revertants | ENNG | ENNG | ENNG | 4NQO | 9AA | ||||||
3 µg | 5 µg | 2 µg | 0.2 µg | 80 µg | ||||||||
510 462 487 | (486) 24.0 | 294 276 228 | (266) 34.1 | 501 941 480 | (641) 260.3 | 159 149 130 | (146) 14.7 | 327 274 591 | (397) 169.8 | |||
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
F Test Item Film
S Sparse bacterial background lawn
V Very weak bacterial background lawn
# Standard deviation
Test Results: Experiment 1 – With Metabolic Activation (Plate Incorporation)
Test Period | From: 16 October 2018 | To: 19 October 2018 | |||||||||||
S9-Mix (+) | Dose Level Per Plate | Number of revertants (mean) +/- SD | |||||||||||
Base-pair substitution strains | Frameshift strains | ||||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||||
Solvent Control (Acetone) | 119 112 129 | (120) 8.5# | 16 20 19 | (18) 2.1 | 29 32 34 | (32) 2.5 | 37 38 43 | (39) 3.2 | 34 12 21 | (22) 11.1 | |||
1.5 µg | 133 132 128 | (131) 2.6 | 30 12 21 | (21) 9.0 | 34 38 38 | (37) 2.3 | 33 28 34 | (32) 3.2 | 18 23 10 | (17) 6.6 | |||
5 µg | 142 139 134 | (138) 4.0 | 19 20 35 | (25) 9.0 | 39 29 32 | (33) 5.1 | 31 32 27 | (30) 2.6 | 25 12 22 | (20) 6.8 | |||
15 µg | 134 109 123 | (122) 12.5 | 24 22 11 | (19) 7.0 | 35 45 28 | (36) 8.5 | 33 40 38 | (37) 3.6 | 18 16 14 | (16) 2.0 | |||
50 µg | 125 133 112 | (123) 10.6 | 21 15 15 | (17) 3.5 | 43 26 39 | (36) 8.9 | 30 31 35 | (32) 2.6 | 24 8 6 | (13) 9.9 | |||
150 µg | 123 91 112 | (109) 16.3 | 19 15 13 | (16) 3.1 | 35 28 22 | (28) 6.5 | 24 37 29 | (30) 6.6 | 8 5 18 | (10) 6.8 | |||
500 µg | 109 124 107 | (113) 9.3 | 25 11 10 | (15) 8.4 | 39 34 32 | (35) 3.6 | 26 27 24 | (26) 1.5 | 7 9 15 | (10) 4.2 | |||
1500 µg | 99 121 132 | (117) 16.8 | 14 9 16 | (13) 3.6 | 31 40 29 | (33) 5.9 | 37 21 28 | (29) 8.0 | 21 14 15 | (17) 3.8 | |||
5000 µg | 130 SF 127 SF 115 SF | (124) 7.9 | 17 F 11 F 13 F | (14) 3.1 | 26 SF 35 SF 31 SF | (31) 4.5 | 35 F 29 F 38 F | (34) 4.6 | 11 F 8 F 10 F | (10) 1.5 | |||
Positive controls S9-Mix (+) | Name Dose Level No. of Revertants | 2AA | 2AA | 2AA | BP | 2AA | |||||||
1 µg | 2 µg | 10 µg | 5 µg | 2 µg | |||||||||
1776 1794 1909 | (1826) 72.2 | 293 241 244 | (259) 29.2 | 174 208 207 | (196) 19.3 | 182 170 198 | (183) 14.0 | 240 242 176 | (219) 37.5 | ||||
BP Benzo(a)pyrene
2AA 2-Aminoanthracene
F Test Item Film
S Sparse bacterial background lawn
# Standard deviation
Test Results: Experiment 2 – Without Metabolic Activation (Pre-Incubation)
Test Period | From: 23 October 2018 30 October 2018 † | To: 26 October 2018 02 November 2018 † | ||||||||||
S9-Mix (-) | Dose Level Per Plate | Number of revertants (mean) +/- SD | ||||||||||
Base-pair substitution strains | Frameshift strains | |||||||||||
TA100 † | TA1535 | WP2uvrA | TA98 † | TA1537 † | ||||||||
Solvent Control (Acetone) | 134 143 142 | (140) 4.9# | 12 9 8 | (10) 2.1 | 19 27 21 | (22) 4.2 | 24 26 25 | (25) 1.0 | 25 10 19 | (18) 7.5 | ||
0.05 µg | 141 136 159 | (145) 12.1 | N/T | N/T | 17 18 32 | (22) 8.4 | 3 10 19 | (11) 8.0 | ||||
0.15 µg | 159 158 123 | (147) 20.5 | N/T | N/T | 22 15 22 | (20) 4.0 | 29 22 8 | (20) 10.7 | ||||
0.5 µg | 140 137 157 | (145) 10.8 | N/T | N/T | 26 31 19 | (25) 6.0 | 26 13 10 | (16) 8.5 | ||||
1.5 µg | 156 143 142 | (147) 7.8 | 16 7 10 | (11) 4.6 | 25 18 21 | (21) 3.5 | 19 30 27 | (25) 5.7 | 21 13 11 | (15) 5.3 | ||
5 µg | 133 145 140 | (139) 6.0 | 7 8 8 | (8) 0.6 | 21 22 27 | (23) 3.2 | 20 21 30 | (24) 5.5 | 14 15 17 | (15) 1.5 | ||
15 µg | 157 122 136 | (138) 17.6 | 12 12 12 | (12) 0.0 | 21 24 19 | (21) 2.5 | 30 30 22 | (27) 4.6 | 28 10 11 | (16) 10.1 | ||
50 µg | 114 S 127 S 103 S | (115) 12.0 | 8 6 8 | (7) 1.2 | 23 30 23 | (25) 4.0 | 20 S 19 S 20 S | (20) 0.6 | 5 S 6 S 9 S | (7) 2.1 | ||
150 µg | 134 S 117 S 129 S | (127) 8.7 | 11 S 6 S 9 S | (9) 2.5 | 12 S 17 S 16 S | (15) 2.6 | 8 S 17 S 14 S | (13) 4.6 | 4 S 6 S 3 S | (4) 1.5 | ||
500 µg | N/T | 9 S 8 S 11 S | (9) 1.5 | 21 S 25 S 21 S | (22) 2.3 | N/T | N/T | |||||
1500 µg | N/T | 8 V 13 V 8 V | (10) 2.9 | 15 S 17 S 15 S | (16) 1.2 | N/T | N/T | |||||
5000 µg | N/T | 13 VF 6 VF 6 VF | (8) 4.0 | 16 SF 10 SF 25 SF | (17) 7.5 | N/T | N/T | |||||
Positive controls S9-Mix (-) | Name Dose Level No. of Revertants | ENNG | ENNG | ENNG | 4NQO | 9AA | ||||||
3 µg | 5 µg | 2 µg | 0.2 µg | 80 µg | ||||||||
399 453 328 | (393) 62.7 | 467 635 438 | (513) 106.4 | 881 779 792 | (817) 55.5 | 136 172 152 | (153) 18.0 | 131 176 129 | (145) 26.6 | |||
† Experimental procedure repeated at a later date due to toxicity in the original test
ENNG N-ethyl-N'-nitro-N-nitrosoguanidine
4NQO 4-Nitroquinoline-1-oxide
9AA 9-Aminoacridine
F Test Item Film
N/T Not tested at this dose level
S Sparse bacterial background lawn
V Very weak bacterial background lawn
# Standard deviation
Test Results: Experiment 2 – With Metabolic Activation (Pre-Incubation)
Test Period | From: 23 October 2018 | To: 26 October 2018 | ||||||||||
S9-Mix (+) | Dose Level Per Plate | Number of revertants (mean) +/- SD | ||||||||||
Base-pair substitution strains | Frameshift strains | |||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | ||||||||
Solvent Control (Acetone) | 76 80 84 | (80) 4.0# | 9 11 14 | (11) 2.5 | 40 31 37 | (36) 4.6 | 19 30 47 | (32) 14.1 | 8 13 14 | (12) 3.2 | ||
1.5 µg | 79 79 83 | (80) 2.3 | 13 14 12 | (13) 1.0 | 38 36 35 | (36) 1.5 | 32 41 29 | (34) 6.2 | 9 19 12 | (13) 5.1 | ||
5 µg | 90 76 78 | (81) 7.6 | 20 7 12 | (13) 6.6 | 27 28 28 | (28) 0.6 | 40 33 32 | (35) 4.4 | 6 9 13 | (9) 3.5 | ||
15 µg | 93 95 88 | (92) 3.6 | 7 7 8 | (7) 0.6 | 40 21 21 | (27) 11.0 | 35 37 30 | (34) 3.6 | 12 15 9 | (12) 3.0 | ||
50 µg | 86 103 78 | (89) 12.8 | 8 10 8 | (9) 1.2 | 25 23 35 | (28) 6.4 | 31 34 36 | (34) 2.5 | 14 12 8 | (11) 3.1 | ||
150 µg | 68 84 79 | (77) 8.2 | 11 12 22 | (15) 6.1 | 31 40 44 | (38) 6.7 | 19 27 25 | (24) 4.2 | 8 12 14 | (11) 3.1 | ||
500 µg | 80 S 70 S 74 S | (75) 5.0 | 7 8 11 | (9) 2.1 | 24 27 23 | (25) 2.1 | 34 26 29 | (30) 4.0 | 12 9 17 | (13) 4.0 | ||
1500 µg | 50 S 74 S 63 S | (62) 12.0 | 15 11 14 | (13) 2.1 | 17 23 33 | (24) 8.1 | 16 21 42 | (26) 13.8 | 8 4 8 | (7) 2.3 | ||
5000 µg | 53 VF 79 VF 62 VF | (65) 13.2 | 10 SF 18 SF 6 SF | (11) 6.1 | 26 F 34 F 41 F | (34) 7.5 | 40 F 23 F 16 F | (26) 12.3 | 11 F 9 F 9 F | (10) 1.2 | ||
Positive controls S9-Mix (+) | Name Dose Level No. of Revertants | 2AA | 2AA | 2AA | BP | 2AA | ||||||
1 µg | 2 µg | 10 µg | 5 µg | 2 µg | ||||||||
1260 1179 1024 | (1154) 119.9 | 245 231 226 | (234) 9.8 | 144 152 150 | (149) 4.2 | 74 87 91 | (84) 8.9 | 208 170 159 | (179) 25.7 | |||
BP Benzo(a)pyrene
2AA 2-Aminoanthracene
F Test Item Film
S Sparse bacterial background lawn
V Very weak bacterial background lawn
# Standard deviation
Applicant's summary and conclusion
- Conclusions:
- In this Reverse Mutation Assay ‘Ames Test’ using strains of Salmonella typhimurium and Escherichia coli (OECD TG 471) the test item Turmeric leaf oil did not induce an increase in the frequency of revertant colonies at any of the dose levels used either with or without metabolic activation (S9-mix). Under the conditions of this test Turmeric leaf oil was considered to be non-mutagenic.
- Executive summary:
Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA were treated with the test item using both the Ames plate incorporation and pre-incubation methods at eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors). The dose range for Experiment 1 (plate incorporation) was based on OECD TG 471 and was 1.5 to 5000 μg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was initially the same as Experiment 1 (1.5 to 5000 μg/plate). However, results from the second mutation test (pre-incubation method) showed that the toxicity of the test item yielded results that differed significantly from Experiment 1 and consequently an insufficient number of non-toxic dose levels were attained for TA100, TA98 and TA1537 in the absence of metabolic activation (S9-mix). Therefore, these strains were repeated employing an amended test item dose range of 0.05 to 150 μg/plate. Eight test item concentrations per bacterial strain were selected in Experiment 2 in order to achieve both four non-toxic dose levels and the toxic limit of the test item following the change in test methodology.
The vehicle (acetone) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The maximum dose level of the test item in the first experiment was selected as the OECD TG 471 recommended dose level of 5000 μg/plate. In the first experiment (plate incorporation method) the test item caused a visible reduction in the growth of the bacterial background lawns and/or substantial reductions in the revertant colony frequency of all the tester strains dosed in the absence of metabolic activation (S9-mix), initially from 500 μg/plate. In the presence of metabolic activation (S9-mix), the test item caused a visible reduction in the growth of the bacterial background lawns or substantial reductions in the revertant colony frequency of tester strains TA100, TA1537 and WP2uvrA at 5000 μg/plate.
Based on the results of Experiment 1, the same maximum dose level (5000 μg/plate) was initially employed in the second mutation test (pre-incubation method). However, as previously described, the test item induced a much stronger toxic response employing the pre-incubation methodology and three tester strains had to be repeated using the toxic limit as the maximum dose. In the absence of metabolic activation (S9-mix), the test item caused a visible reduction in the growth of the bacterial background lawns of all of the tester strains, initially from 50 μg/plate. In the presence of metabolic activation (S9-mix), the test item caused a visible reduction in the growth of the bacterial background lawns of tester strains TA100, and TA1535 from 500 and at 5000 μg/plate, respectively.
A slight test item film was noted by eye at 5000 μg/plate in both the presence and absence of metabolic activation (S9-mix) in Experiments 1 and 2. This observation did not prevent the scoring of revertant colonies.
There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method).
Similarly, no significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method).
Turmeric leaf oil was considered to be non-mutagenic under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.